This could be the result of a doctoral dissertation by Charlotte Eklund-Jonsson at the Department of Food Science.The food, called tempe, is moreover a whole-grain product with high folate content. It is generally accepted in medicine that whole-grains reduce the risk of cardiovascular diseases, and it is also believed that it protects against age-related diabetes and certain forms of cancer.

During menopause, lack of oestrogens increases the risk of suffering cardiovascular diseases. For her doctoral thesis, University of the Basque Country researcher, Ainhoa Ruiz del Agua, studied the effects of substitute treatments and the genetic factors influencing the response to these therapies.Menopause is a natural period in the ageing process of a woman.

“Are you taking or did you take hormones? If yes, which hormone medication and for how long? When did you stop taking hormone replacement medication?” 3,464 breast cancer patients and 6,657 healthy women between the ages of 50 and 74 years participated in a large survey and elicited detailed information about hormone replacement medications they are taking or used to take for relief of menopausal symptoms.

Researchers at The University of Nottingham have taken some important first steps to creating a synthetic copycat of a living cell, a leading science journal reports.Dr Cameron Alexander and PhD student George Pasparakis in the University’s School of Pharmacy have used polymers - long-chain molecules - to construct capsule-like structures that have properties mimicking the surfaces of a real cell.

For more than 40 years, Earth observing satellites have delivered valuable data about our planet and have enabled a better understanding and improved management of the Earth and its environment. Demands for these data are increasing daily as decision-makers are faced with responding to environmental change, managing sustainable development and responding to natural disasters and civil security issues.

The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) have announced a multi-year partnership to jointly sponsor the ACC i2 interventional cardiology meeting in Orlando, Fla., March 28-31, 2009, during ACC.09, the ACC’s 58th Annual Scientific Session and the world’s premier cardiovascular meeting. This will be the beginning of a five-year partnership committed to collectively developing the interventional component of the ACC Annual Scientific Session.

GenVec, Inc. (Nasdaq:GNVC) presented an overview of TNFerade” development and an update on long-term survival data from its Phase II clinical trial using TNFerade in patients with esophageal cancer at the American Society of Gene Therapy (ASGT) 11th Annual Meeting in Boston, MA. Dr.

The gene that allows fireflies to flash is helping researchers track the effectiveness of anti-cancer drugs over time.UT Southwestern Medical Center researchers are among the first to show that a technique called bioluminescence imaging (BLI) can be used to determine the effectiveness of cancer drugs that choke off a tumor’s blood supply.The technique requires a substrate called luciferin to be added to the bloodstream, which carries it to cells throughout the body.

Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center. The findings could mean that identifying patients with poor quality of life could also identify patients with particularly aggressive tumors.”Low quality of life may have value in screening patients for recurrence.

A significant number of patients who suffer a heart attack never have any warning signs. For many of these individuals, the source of the problem is noncalcified plaque, a buildup of soft deposits embedded deep within the walls of the heart’s arteries, undetectable by angiography or cardiac stress tests - and prone to rupture without warning.Now a new noninvasive method has shown success in detecting and measuring noncalcified plaque.